OFFER AND SUPPORT AGREEMENTOffer and Support Agreement • April 16th, 2018 • TiGenix NV • Pharmaceutical preparations
Contract Type FiledApril 16th, 2018 Company Industry
PATENT LICENSE AND SETTLEMENT AGREEMENTPatent License and Settlement Agreement • April 16th, 2018 • TiGenix NV • Pharmaceutical preparations • New York
Contract Type FiledApril 16th, 2018 Company Industry JurisdictionThis PATENT LICENSE AND SETTLEMENT AGREEMENT is entered into as of December 14, 2017 (the “Effective Date”) by and between, on the one hand, Mesoblast Inc., a Delaware corporation, with a place of business at 505 Fifth Avenue, New York, New York 10017 U.S.A. (“Mesoblast Inc.”) and Mesoblast International Sàrl, a Swiss societé à responsibilité limitée, with a place of business located at Route de Pre-Bois 20, c/o Accounting & Management Service SA, 1217 Meyrin, Switzerland (“Mesoblast Sàrl,” and together with Mesoblast Inc., “MSB”) and, on the other hand, TiGenix S.A.U., a Spanish corporation, with a place of business at Calle Marconi 1, Parque Tecnológico de Madrid, 28760 Tres Cantos (Madrid), Spain (“TiGenix”); each of MSB and TiGenix may be hereinafter referred to together as the “Parties” and individually as a “Party” when convenient.